The Characteristics of Pediatric Patients with Familial Mediterranean Fever Treated with Anti-Interleukin-1 Treatment

AVAR AYDIN P. Ö., ÖZÇAKAR Z. B., AYDIN F., KARAKAŞ H. D., ÇAKAR N., Yalcinkaya F.

TURKISH ARCHIVES OF PEDIATRICS, vol.57, no.4, pp.448-452, 2022 (ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 57 Issue: 4
  • Publication Date: 2022
  • Doi Number: 10.5152/turkarchpediatr.2022.22039
  • Journal Name: TURKISH ARCHIVES OF PEDIATRICS
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.448-452
  • Keywords: Anakinra, canakinumab, familial Mediterranean fever, IL-1 inhibitors, pediatrics, ACUTE-PHASE RESPONSE, COLCHICINE, ACTIVATION, MUTATIONS
  • Ankara University Affiliated: Yes

Abstract

Objective: Interleukin-1 inhibitors are effective agents used in colchicine resistance or intolerance during the treatment of familial Mediterranean fever. This study aims to review the characteristics of patients treated with interleukin-1 inhibitors and their long-term follow-up in a large pediatric cohort of familial Mediterranean fever patients.